Insider Cluster (2 insiders) ·Filed Mar 16, 2026

CYRX

Cryoport, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 4 insiders, $0.1M total
Actionable Insight • Neutral

The activity appears to be routine option exercise and limited share sales, likely for tax or personal liquidity purposes. No material signal of distress or confidence. Monitor for increased selling volume or broader insider participation.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CYRX ▲ +93.50% at T+60d
NEUTRAL call ✓ call won +93.50% · α vs SPY +83.02% · entry $8.00 → $15.48
Entry anchored
Mar 13, 03:59 PM ET
via exchange tick
T+1d
+4.50%
call +4.50% · α +4.23%
$8.36
settled 7mo ago
T+5d
+1.88%
call +1.88% · α +3.92%
$8.15
settled 7mo ago
T+20d
+24.38%
call +24.38% · α +20.60%
$9.95
settled 6mo ago
T+60d
+93.50%
call +93.50% · α +83.02%
$15.48
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Cryoport CEO Jerrell Shelton exercised options for 50,000 shares and sold 2,894 shares in open market for $23,673, while CSO Mark Sawicki sold 1,341 shares for $10,969. The majority of activity consists of non-cash derivative exercises, with minimal open-market selling by two executives.

Key Financial Metrics

Direction
selling
Total Value
$34.6K
Insiders
2

Key Facts

  • CEO Jerrell Shelton exercised 50,000 derivative securities on March 23, 2026, with 25,000 at $1.87 and 25,000 at $0, totaling $46,750 in value.
  • CEO sold 2,894 shares in the open market at $8.18 for proceeds of $23,672.92.
  • CSO Mark Sawicki sold 1,341 shares at $8.18 for $10,969.38.
  • Total open-market sales by insiders in the cluster: $34,642.30.
  • Total recent insider sales over 30 days: $162K, representing 0.04% of the $406M market cap.

Financial Impact

Minimal open-market selling totaling $34,642 over 7 days, with total recent sales of $162K (0.04% of market cap). Non-cash derivative exercises dominate the activity.

insider ownershipshare count (dilution potential)

Risk Factors

  • Potential perception of insider selling, though magnitude is trivial relative to market cap.
  • Dilution from exercised options, though standard for equity compensation plans.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-CYRX-1774483239967
5 reports for CYRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYRX — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$15.25 $15.96▲ +4.66%▲ +6.65%$17.43 (+14.30%)
Jun 21, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$14.77 $16.51▲ +11.78%▲ +11.93%$17.43 (+18.01%)
Jun 12, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$14.83 $15.71▲ +5.93%▲ +6.68%$17.43 (+17.53%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 26, 2026